BRIEF-Aprea Therapeutics Announces Twice Daily (Bid) Dosing Of Patients In ABOYA-119 Clinical Trial Of ATRN-119 To Potentially Optimize Clinical Outcomes

Reuters
2024-12-11

Dec 11 (Reuters) - Aprea Therapeutics :

* APREA THERAPEUTICS ANNOUNCES TWICE DAILY $(BID.AU)$ DOSING OF PATIENTS IN ABOYA-119 CLINICAL TRIAL OF ATRN-119 TO POTENTIALLY OPTIMIZE CLINICAL OUTCOMES AND STRENGTHEN CLINICAL PATH FORWARD

* APREA THERAPEUTICS- DOSE ESCALATION IN ABOYA-119 TRIAL EXPECTED TO CONTINUE WITH BOTH ONCE-DAILY & TWICE-DAILY DOSING SCHEDULES

* APREA THERAPEUTICS INC -ANTICIPATES PHASE 1 READOUT IN SECOND HALF OF 2025

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10